Capital One CEO Richard Fairbank Has Sold $924 Million in COF Stock — On a $0 Salary
The only major-bank CEO who takes zero salary. Richard Fairbank exercises options at $63.73 and sells at $220+ in coordinated mega-blocks. Two October-November sessions alone netted $46.2M.
Richard Fairbank is the only major-bank CEO in America who takes zero salary. No base pay. No cash bonus. His entire compensation comes as stock options in Capital One Financial (COF) — and he has been methodically converting those options into cash for over two decades.
Career total: $924,381,419 in COF stock sales across 14,374 Form 4 transactions. In October-November 2025 alone, two mega-block exercise-and-sell sessions generated approximately $46.2 million.
The exercise-and-sell machine
Fairbank’s pattern is distinct from the daily-drip sellers. Instead of small daily lots, he concentrates activity into periodic large blocks: exercise tens of thousands of options at the grant strike price, then immediately sell the shares at market price. Two recent sessions tell the story:
| Date | Options Exercised | Exercise Price | Shares Sold | Avg Sell Price | Est. Proceeds |
|---|---|---|---|---|---|
| Oct 27, 2025 | 53,486 | $63.73 | 103,486 | ~$225.80 | ~$23.4M |
| Nov 4, 2025 | 53,487 | $63.73 | 103,487 | ~$220.40 | ~$22.8M |
The economics: exercise at $63.73, sell at $218-$227. That is a $157-$163 spread per share — a 250%+ gain on the exercise price. Both sessions followed the same structure: exercise options in one account, sell shares across 8-10 lots throughout the day, complete the entire cycle within hours.
The zero-salary model
Fairbank founded Capital One in 1994 and has served as CEO ever since — 30+ years. His compensation structure is unique among top-20 US bank CEOs:
- Base salary: $0 (since founding)
- Cash bonus: $0
- Stock awards: Received 76,675 + 76,676 shares in June 2025 (two grants)
- Options: Periodic grants, typically with multi-year vesting
This means every dollar Fairbank earns from Capital One comes through selling stock. His $924M in career sales is his compensation, not a supplement to it.
2025 activity summary
| Date | Activity | Details |
|---|---|---|
| Feb 15 | Exercise + disposition | 36,195 options, disposed at $201.77 |
| Mar 10 | Awards + tax withholding | 115,438 shares awarded, 52,064 withheld for tax |
| Jun 3 | Stock awards | 153,351 shares received (two grants) |
| Oct 27 | Exercise + sell | 53,486 options at $63.73, sold 103,486 shares ~$23.4M |
| Nov 4 | Exercise + sell | 53,487 options at $63.73, sold 103,487 shares ~$22.8M |
After the November sale, Fairbank holds approximately 4,001,228 shares of COF, worth roughly $880 million at ~$220 per share.
What to watch
- Whether more $63.73-strike options remain — if so, Fairbank has strong incentive to exercise before expiration given the 250%+ spread.
- Capital One’s pending Discover Financial acquisition and how deal completion might affect Fairbank’s selling timeline.
- New option or equity grants at the 2026 annual meeting — watch for grants that would reset his selling runway.
- Any changes to the zero-salary compensation model in proxy filings.
Related Research
Explore all researchKEYBANK NATIONAL ASSOCIATION/OH reported 27.38B in 2026Q1 13F assets. The filing is most useful as a holder-depth and concentration map, not a raw clone list.
Ninety One UK's 2026Q1 filing put Alphabet, Microsoft, Nvidia, Visa and Johnson & Johnson at the top of a $43.13B reported portfolio.
A data-first review of SEI INVESTMENTS CO's 2025Q4 13F, with emphasis on concentration and top-holder context.
A data-first review of Boston Partners's 2025Q4 13F, with emphasis on concentration and top-holder context.
Pzena Investment Management's 2026Q1 13F looked nothing like a mega-cap AI basket, with Magna, Cognizant, Tyson, Baxter and Bristol Myers among the top holdings.